• OSCC personalized therapy: targeting specific molecular alterations for improved outcomes. • Immunotherapy: harnessing the immune system to combat OSCC. • Biomarkers: guiding treatment decisions and predicting response in OSCC patients. • Challenges: overcoming barriers to implementation and optimizing personalized approaches. • Future directions: advancing research to transform OSCC management with tailored therapies.
No takes yet. Share an insight, caveat, or question.
Patil et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: